Pitch Notes:Dear Editor, Amid ongoing global trade uncertainties and supply chain bottlenecks, localising critical drug development infrastructure in Asia-Pacific has never been more vital. Today, Merck KGaA (not MSD) announced the expansion of its BioReliance® biosafety testing lab in Singapore to over 1,000 sqm, strengthening APAC’s regional self-reliance in biopharma quality control. Key updates: First in APAC: The region’s first ... Read More